Top of the Street: Reckitt, NatWest, DCC, Getinge

Getinge publ AB

02/09/2026 12:06

A round-up of notable broker activity this morning from Europe's top-ranked* analysts:
     
** Exane BNP Paribas cuts UK consumer goods maker Reckitt RKT.L to "neutral" from "outperform", saying the negative demand impact from GLP-1 weight-loss drugs is "just getting started"
** Morgan Stanley upgrades British lender NatWest NWG.L to "overweight" from "equal weight", saying its strong commercial and institutional lending growth "has legs" and the consensus for other income is achievable
** Berenberg downgrades DCC Energy DCC.L to "hold" from "buy", stepping back as the Irish energy distributor is being acquired by a U.S. consortium
     
INITIATIONS AND REINSTATEMENTS
** UBS initiates Swedish medical technology firm Getinge GETIb.ST with a "neutral" rating, noting that while a portfolio mix shift supports a stronger growth outlook, the current valuation already reflects this recovery in quality
     
(*Analyst rankings from Thomson Reuters StarMine. The scale is from 1-star to 5-star with 5 being the best. Analysts are ranked on earnings accuracy as well as relative performance of recommendations over trailing 12-month & 24-month periods.)

(Reporting by Rafal Nowak and Boleslaw Lasocki in Gdansk)
((RafalWojciech.Nowak@thomsonreuters.com; +48 58 769 66 63;))